Related Experiment Videos
Age-related alterations in inflammatory response during experimental autoimmune prostatitis
G Morón1, B Maletto, M Orsilles
1Departamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba., 5000, Córdoba, Argentina.
Mechanisms of Ageing and Development
|September 16, 2000
Summary
Aging impacts inflammation mediators in experimental autoimmune prostatitis (EAP) models. Aged EAP rats exhibit altered immune responses and mediator production compared to younger rats, highlighting age-related disease modulation.
Area of Science:
- Immunology
- Pathology
- Aging Research
Background:
- Experimental autoimmune prostatitis (EAP) serves as a model for autoimmune disease.
- Age influences immune responses and disease progression in EAP models.
Purpose of the Study:
- To investigate the impact of aging on immune responses and inflammation mediators in EAP.
- To compare cellular and humoral autoimmune responses in young versus aged EAP rats.
Main Methods:
- Induction of EAP in Wistar rats of different age groups (3, 12, and 18 months).
- Analysis of cellular and humoral autoimmune responses.
- Measurement of nitric oxide (NO(.)) and superoxide (O(2)(-)) production by peritoneal exudate cells (PECs).
- Assessment of mast cell degranulation in prostatic tissue.
Main Results:
- Aged EAP rats (12 and 18 months) showed higher cellular and lower humoral autoimmune responses than 3-month-old rats.
- EAP rats exhibited increased NO(.) and O(2)(-) production across all ages compared to controls.
- PECs from aged EAP rats produced more NO(.) and less O(2)(-) than younger rats.
- Lipopolysaccharide (LPS) stimulation of PECs for NO(.) production was reduced in aged rats.
- Increased mast cell numbers and degranulation were observed in the prostates of EAP rats.
Conclusions:
- Aging differentially affects inflammation mediators in EAP.
- Age-dependent alterations in immune cell function and mediator release contribute to EAP pathogenesis.
- These findings provide insights into age-related changes in autoimmune prostatitis.